TABLE OF CONTENTS

1. INTRODUCTION 29
1.1. OBJECTIVES OF THE STUDY 29
1.2. MARKET DEFINITION 29
1.3. OVERVIEW OF GLOBAL PHARMACEUTICAL PACKAGING MARKET 29
1.4. CURRENCY AND PRICING 30
1.5. LIMITATION 30
1.6. MARKETS COVERED 31
2. MARKET SEGMENTATION 34
2.1. MARKETS COVERED 34
2.2. GEOGRAPHIC SCOPE 35
2.3. YEARS CONSIDERED FOR THE STUDY 36
2.4. CURRENCY AND PRICING 36
2.5. RESEARCH METHODOLOGY 37
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 40
2.7. SECONDARY SOURCES 41
2.8. ASSUMPTIONS 41
3. MARKET OVERVIEW 42
3.1. DRIVERS 44
3.1.1. STRICT CONTROL REGULATIONS AND ADMINISTRATION AND QUALIFICATION DEMAND 44
3.1.2. RAPID GROWTH OF THE PHARMACEUTICAL INDUSTRY GLOBALLY 44
3.1.3. INCREASING DEMAND FOR DRUG DELIVERY DEVICES & BLISTER PACKAGING 45
3.1.4. TECHNOLOGICAL ADVANCEMENTS 45
3.2. RESTRAINTS 46
3.2.1. ENVIRONMENTAL CONCERNS AND RECYCLING ISSUES 46
3.2.2. GROWING COST OF RAW MATERIALS 46
3.3. OPPORTUNITIES 47
3.3.1. RISE IN DEMAND FOR PHARMACEUTICAL PACKAGING IN DEVELOPING NATIONS 47
3.3.2. RAPIDLY INCREASING 3PL AND OTHER SERVICES IN EMERGING MARKETS 47
3.3.3. INCREASING HEALTH AWARENESS 48
3.4. CHALLENGES 49
3.4.1. PROTECTION AGAINST COUNTERFEIT PRODUCTS 49
3.4.2. ISSUES IN PROVIDING SERVICES IN THE GROWING ECONOMIES 49
4. EXECUTIVE SUMMARY 50
5. PREMIUM INSIGHTS 53
6. GLOBAL PHARMACEUTICAL PACKAGING MARKET, BY PRODUCT TYPE 56
6.1. OVERVIEW 57
6.2. PLASTIC BOTTLES 59
6.3. BLISTER PACKAGING 60
6.4. DRUG DELIVERY DEVICES 61
6.5. LABELS & ACCESSORIES 62
6.6. CAPS & CLOSURES 63
6.7. SECONDARY CONTAINERS 64
6.8. POUCHES & STRIPS 65
6.9. OTHERS 66
7. GLOBAL PHARMACEUTICAL PACKAGING MARKET, BY APPLICATION 67
7.1. OVERVIEW 68
7.2. DRUG DELIVERY 70
7.2.1. ORAL DRUGS 71
7.2.2. TOPICAL 71
7.2.3. OPHTHALMIC 72
7.2.4. NASAL 72
7.2.5. PULMONARY 72
7.2.6. TRANSDERMAL 72
7.2.7. OTHERS 72
7.3. VETERINARY VACCINES 73
7.3.1. LIVESTOCK VACCINES 74
7.3.2. PORCINE VACCINES 74
7.3.3. POULTRY VACCINES 75
7.3.4. CANINE VACCINES 75
7.3.5. FELINE VACCINES 75
7.3.6. EQUINE VACCINES 75
7.3.7. AQUACULTURE VACCINES 76
7.3.8. OTHERS 76
8. GLOBAL PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL 77
8.1. OVERVIEW 78
8.2. PLASTICS 80
8.2.1. HIGH-DENSITY POLYETHYLENE 81
8.2.2. POLYPROPYLENE 81
8.2.3. LOW-DENSITY POLYETHYLENE 82
8.2.4. OTHERS 82
8.3. PAPER AND PAPER BOARD 83
8.4. METALS 84
8.5. GLASS 85
8.6. OTHERS 86
9. GLOBAL PHARMACEUTICAL PACKAGING MARKET, BY PURCHASE ORGANIZATION 87
9.1. OVERVIEW 88
9.2. MANUFACTURER 90
9.3. PACKAGING COMPANIES 91
9.4. GOVERNMENT AGENCIES 92
10. GLOBAL PHARMACEUTICAL PACKAGING MARKET, BY GEOGRAPHY 93
10.1. OVERVIEW 94
10.2. NORTH AMERICA 101
10.2.1. U.S. 113
10.2.2. CANADA 118
10.2.3. MEXICO 124
10.3. EUROPE 129
10.3.1. GERMANY 141
10.3.2. FRANCE 146
10.3.3. U.K. 151
10.3.4. ITALY 156
10.3.5. SPAIN 161
10.3.6. SWITZERLAND 166
10.3.7. NETHERLANDS 171
10.3.8. TURKEY 176
10.3.9. BELGIUM 181
10.3.10. RUSSIA 186
10.3.11. REST OF EUROPE 191
10.4. ASIA-PACIFIC 192
10.4.1. JAPAN 204
10.4.2. CHINA 209
10.4.3. INDIA 214
10.4.4. SOUTH KOREA 219
10.4.5. AUSTRALIA 224
10.4.6. SINGAPORE 229
10.4.7. THAILAND 234
10.4.8. MALAYSIA 239
10.4.9. INDONESIA 244
10.4.10. PHILIPPINES 250
10.4.11. REST OF ASIA-PACIFIC 255
10.5. SOUTH AMERICA 256
10.5.1. BRAZIL 268
10.5.2. REST OF SOUTH AMERICA 273
10.6. MIDDLE EAST AND AFRICA 274
10.6.1. SOUTH AFRICA 286
10.6.2. REST OF MIDDLE EAST AND AFRICA 291
11. GLOBAL PHARMACEUTICAL PACKAGING MARKET,
COMPANY LANDSCAPE 292
11.1. COMPANY SHARE ANALYSIS; GLOBAL 292
11.2. COMPANY SHARE ANALYSIS; NORTH AMERICA 293
11.3. COMPANY SHARE ANALYSIS; EUROPE 294
11.4. COMPANY SHARE ANALYSIS; Asia-Pacific 295
12. COMPANY PROFILES 296
12.1. BAUSCH + STR?BEL 296
12.1.1. COMPANY OVERVIEW 296
12.1.2. COMPANY SNAPSHOT 296
12.1.3. PRODUCT PORTFOLIO 297
12.1.4. RECENT DEVELOPMENTS 297
12.2. ROBERT BOSCH GMBH (A SUBSIDIARY OF ROBERT
BOSCH STIFTUNG GMBH) 298
12.2.1. COMPANY OVERVIEW 298
12.2.2. REVENUE ANALYSIS 298
12.2.3. PRODUCT PORTFOLIO 299
12.2.4. RECENT DEVELOPMENTS 299
12.3. BECTON, DICKINSON AND COMPANY 300
12.3.1. COMPANY OVERVIEW 300
12.3.2. REVENUE ANALYSIS 300
12.3.3. PRODUCT PORTFOLIO 301
12.3.4. RECENT DEVELOPMENTS 301
12.4. GERRESHEIMER AG 302
12.4.1. COMPANY OVERVIEW 302
12.4.2. REVENUE ANALYSIS 302
12.4.3. PRODUCT PORTFOLIO 303
12.4.4. RECENT DEVELOPMENTS 304
12.5. AMCOR LIMITED 305
12.5.1. COMPANY OVERVIEW 305
12.5.2. REVENUE ANALYSIS 305
12.5.3. PRODUCT PORTFOLIO 306
12.5.4. RECENT DEVELOPMENTS 306
12.6. APTARGROUP, INC. 307
12.6.1. COMPANY OVERVIEW 307
12.6.2. REVENUE ANALYSIS 307
12.6.3. PRODUCT PORTFOLIO 308
12.6.4. RECENT DEVELOPMENTS 309
12.7. SCHOTT AG 310
12.7.1. COMPANY OVERVIEW 310
12.7.2. REVENUE ANALYSIS 310
12.7.3. PRODUCT PORTFOLIO 311
12.7.4. RECENT DEVELOPMENTS 311
12.8. LONZA 312
12.8.1. COMPANY OVERVIEW 312
12.8.2. REVENUE ANALYSIS 312
12.8.3. PRODUCT PORTFOLIO 313
12.8.4. RECENT DEVELOPMENTS 313
?
12.9. DU PONT 314
12.9.1. COMPANY OVERVIEW 314
12.9.2. REVENUE ANALYSIS 314
12.9.3. PRODUCT PORTFOLIO 315
12.9.4. RECENT DEVELOPMENTS 315
13. RELATED REPORTS 316